Freestone Grove Partners »

Aktis Oncology shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $64 2 32.00

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Us Bancorp Com New (USB)
Raytheon Technologies Corp (RTX)
Ge Aerospace Com New (GE)
Crane Company Common Stock (CR)
American Intl Group Com New (AIG)
Snowflake Com Shs (SNOW)
Fortune Brands (FBIN)
Johnson & Johnson (JNJ)
Abbott Laboratories (ABT)
Axis Cap Hldgs SHS (AXS)
Keurig Dr Pepper (KDP)
Microsoft Corporation (MSFT)

View all positions for Freestone Grove Partners

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
BlackRock
Wellington Management Company
Rtw Investments
T. Rowe Price Associates
Henderson Group
RA Capital Management
Jupiter Topco
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
TCG Crossover Management

View all funds holding Aktis Oncology